Despite new market entrants in the form of Gilead's Livdelzi and Ipsen's Iqirvo, US gastroenterologists report nearly half of PBC patients suffer fro ...

The treatment landscape for primary biliary cholangitis (PBC) has undergone a marked transformation over the past year, driven by the recent approvals ...

Hepatitis and fatty liver disease, major causes of chronic liver injury, often present with subtle, easily overlooked ...

Mirum Pharmaceuticals MIRM has delivered a stellar performance over the past three months. Shares of the company have rallied ...

原发性胆汁性胆管炎(PBC)是一种以肝脏小胆管为主要靶器官的慢性进展性自身免疫性胆汁淤积性疾病[1]。首都医科大学附属北京友谊医院贾继东教授作了“原发性胆汁性胆管炎的诊断与治疗——有时容易，有时难”学术分享，现整理要点供读者参考。一、PBC的流行病学 ...

Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that the portfolio company Umecrine Cognition has raised ...

Franz Aren Babao Reyes, 23, got a new lease on life after receiving a liver transplant — the first ever at Makati Medical ...

The ZenoTOF 8600 system was used to measure the bile acid content of human plasma sample extracts using both CID- and ...

Advanz Pharma's bid to keep its Ocaliva treatment for rare liver disease primary biliary cholangitis (PBC) on the EU market has ended in failure.

Mononucleosis is common among youth, and researchers now believe stopping the virus may also reduce the risk of developing ...

Sue was clinging to life by a thread after she was diagnosed with a deadly liver condition, and doctors told her she wouldn't ...